Kogure, Y., Hashimoto, H., Tanaka, K., Ninomiya, T., Ishikawa, N., Numata, T., Fujiwara, K., Kudo, K., Watanabe, H., Yamamoto, N., Oki, M., Yamaguchi, M. (2026). A randomized phase III study of pembrolizumab versus pembrolizumab with carboplatin plus pemetrexed for locally advanced or metastatic nonsquamous non–small cell lung cancer with PD-L1 TPS ≥ 50%: LAPLACE-50.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8554